Shopping Cart
Remove All
Your shopping cart is currently empty
Anticanceragent 241 (HZ1) is a novel orally active inhibitor specifically targeting cell cycle-dependent kinase-like 3 (CDKL3). It demonstrates potent antitumor effects and has the potential to overcome resistance to CDK4/6 inhibitors.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 4-6 weeks | 4-6 weeks | |
| 50 mg | $1,980 | 4-6 weeks | 4-6 weeks | |
| 100 mg | $2,500 | 4-6 weeks | 4-6 weeks |
| Description | Anticanceragent 241 (HZ1) is a novel orally active inhibitor specifically targeting cell cycle-dependent kinase-like 3 (CDKL3). It demonstrates potent antitumor effects and has the potential to overcome resistance to CDK4/6 inhibitors. |
| In vitro | Anticancer agent 241 (HZ1; 100 nM) notably diminishes the levels of pRb and CDK4, effectively inducing cell cycle arrest and tumor cell death. |
| In vivo | Anticancer agent 241 (HZ1; 1 mg/kg; oral gavage; daily for 12-14 days) exhibits anticancer activity in a mouse colon cancer model. |
| Molecular Weight | 362.43 |
| Formula | C20H22N6O |
| Cas No. | 3030492-40-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.